HLAA’s Patient-Focused Drug Development Meeting (Tuesday, May 25, 2021) HLAA received permission from the U.S. Food & Drug Administration (FDA) to hold an Externally-Led Patient-Focused Drug Development Meeting for People and Families Living with Sensorineural Hearing Loss on Tuesday, May 25, from 10 a.m.-3 p.m. (U.S. ET). This meeting represents the voice of the person … Continue reading Patient-Focused Drug Development Meeting led by HLAA